Nanotechnology firm receives nearly $400K

Mississauga nanotechnology developer and manufacturer Integran Technologies Inc. has received a repayable loan of nearly $400,000 from the federal government for a new development project. The company is developing nano-structured aerospace and defence products. The money will be used to create "next-generation metal alloys that are more robust and free from toxic beryllium copper," which will help expand the company's product line and its customer base. Industry Minister Christian Paradis said the money will come from the Strategic Aerospace and Defence Initiative, which supports industrial research and development projects in the aerospace, defence, space and security industries. "By investing in innovative firms like Integran, our government is ensuring that Canada's aerospace and defence industry remains a global leader and continues to be a major contributor to our economy," said Paradis. "This support will allow Integran to realize new market opportunities in an emerging market segment." As part of the initiative, Integran will work with graduate-level engineering students from the University of Toronto. "Since being founded over 12 years ago, Integran has been committed to developing environmentally benign alternatives to toxic materials and processes," said company president and chief executive officer Gino Palumbo. "Integran is confident that through this program, our core patented nanotechnology can be optimized and demonstrated to be a viable, cost-effective alternative to the alloying of copper with toxic beryllium - a strengthening process that remains in widespread use for various industrial, aerospace and defence applications." cclay@mississauga.net

Hoskins speaks on mental health

Children and Youth Services Minister Eric Hoskins was in Mississauga today to announce $1.36 million in new provincial funding for Peel children with mental health challenges.

Teacher earns cycling award

Glenforest Secondary School teacher George Douzenis was recognized this morning by City Council for his work promoting cycling in Mississauga.

Read more:

Nanotechnology firm receives nearly $400K

Research and Markets: Nanotechnology for Drug Delivery: Global Market for Nanocrystals – Drug Nanocrystal Market Will …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/ths3db/nanotechnology_for) has announced the addition of the "Nanotechnology for Drug Delivery: Global Market for Nanocrystals" report to their offering.

Nanocrystals will account for 60% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nanocrystals and nanocarriers respectively.

Since we now understand that most (if not all) biological processes occur at the nanoscale, the application of life science principles - studying the causes of biological phenomena at the molecular level - means that medical and biomedical research is increasingly using a bottom-up (rather than the top-down) approach.

The healthcare market is changing. The author is seeing a paradigm shift away from blockbusters and a one-size fits all' approach to a more personalised medicine based on an individual's unique genome and immune response. The more scientists learn about the molecular causes for disease the more targeted and effective nanotechnology-enabled drug delivery therapies will become.

Nanocrystals will outperform nanocarriers by 20%

Nanocrystal-based drugs showed the highest market growth in the last decade compared to other nanotechnology-enabled drug delivery systems studied, according to Cientifica Ltd.'s latest research. This is largely due to the shorter development times and smaller investment needed to create nanocrystals. The report presents a detailed discussion of recent developments (2000-2010) in nanocrystal therapies and future opportunities (2011-2021).

The low bioavailability resulting from traditional oral (both tablet and liquid) drug delivery methods and the market forces at work in the pharmaceutical industry - where patents expire after a relatively short period of time unless a novel form of drug delivery is developed that will extend the patent - are two major forces that will fuel the growth of the nanotech enabled drug delivery market, said Harper.

The National Science Foundation has forecast the global nanotech-enabled market will reach US$1 trillion by 2015, while the National Nanotechnology Initiative predicts it will reach US$3 trillion by 2020. Drug nanocrystals would therefore account for approximately 2.5% of the total global nanotechnology market in 2015 and 3.5% in 2021.

For more information visit http://www.researchandmarkets.com/research/ths3db/nanotechnology_for

See the article here:

Research and Markets: Nanotechnology for Drug Delivery: Global Market for Nanocrystals - Drug Nanocrystal Market Will ...

Cracking study makes nanotech breakthrough

The Korea Herald/Asia News Network Thursday, May 10, 2012

Korean scientists have developed technology that can control the way a solid material cracks for the first time in a breakthrough that could have applications in a range of fields from semiconductors to medicine.

The research was featured on the cover of Wednesday's issue of Nature. It is the first time a Korean study has been on the cover of the world's most authoritative scientific journal.

Nam Koo-hyun of Ewha Womans University, who led the research, said his discovery may pave the way for the development of a cheaper and quicker way to produce nano-channels.

His team is the first to discover a technique to control cracking and make use of it, he said.

"The formation of cracks is traditionally considered an unpleasant phenomenon because we thought it is impossible to control," Nam told The Korea Herald.

Nam's team used silicon wafers, thin slices of semiconductor material, in their experiment.

They created micro-scaled cuts in a thin brittle film deposited on the silicon in order to control the starting point of cracking, and put a "crack-stop-structure" to terminate the cracking.

"By doing this we can place the starting point of cracking very precisely, and even control the direction of the cracks and bend them around corners," Nam told The Korea Herald.

The nano-channels that are small enough to allow ions or molecules of a certain size to pass through are highly in demand in chemistry and molecular biology, such as DNA analysis.

Follow this link:

Cracking study makes nanotech breakthrough

Research and Markets: Global Market for Nano Silver

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/49pt57/global_market_for) has announced the addition of the "Global Market for Nano Silver" report to their offering.

Nanomaterials have enormous potential and are slated as materials for the future technologies. There are several specific type of nanomaterials already developed in the marketplace and Nano Silver is one such material which has the potential to be used across various industries. Relatively increased chemical reactivity and quantum effects are expected to make Nanomaterials more cost effective products in the medium term.

We are proud to present the readers with the first research on the nano materials subject. Versatile applications combined with cost effective manufacturing method makes nano silver , a product of the future. Despite enormous potential, nano silver remains unknown to most of the global producers and hence the product could not live up to its true potential. In this report, we have attempted to uncover some of the characteristics , features and benefits of this revolutionary product which can help change the prospects of most of the industries.

Nano Silver exhibits antibacterial as well as conductive properties. Therefore due to its antimicrobial nature, it finds use in various applications, ranging from healthcare, plastics, food packaging while the conductive properties makes it find application in electronics, conductors, touch screen etc. However, 80% of nano silver is presently used as an antibacterial agent. Existing players in the field of drug manufacture, food packaging, textiles, detergents, solar cells, consumer electronics, sensors etc will find the report more useful as it opens up a whole new world of business opportunities. The emerging application areas where research efforts are underway are again in the fields of medicine and a few in the area of conductive applications.

The current global consumption of nano silver is estimated to be in the range of 800 MT. North America is the largest consumer of Nano Silver by volume followed by Europe. However, 60% of the global capacity is located in Asia especially in China and Korea. Nano Silver is sold in two forms - solid powder and liquid solution. There two main processes for manufacture of nano silver are Control Detonation System and Hot Plasma Jet System. The price and quality of the nano silver is dependent on the particle synthesis method used.

Key Topics Covered:

- 1 EXECUTIVE SUMMARY

- 2 METHODOLOGY

- 3 INTRODUCTION

More:

Research and Markets: Global Market for Nano Silver

Kids visit Nano College after Obama

Posted at: 05/09/2012 5:08 PM | Updated at: 05/09/2012 6:24 PM By: Andrew Murphy

By mere coincidence, Wednesday was career day at the College of Nanoscale Science and Engineering. About 300 middle and high school students roamed around as the staff recounted their day with the leader of the free world.

Were they nervous, of course, But Chris Borst and Warren Montgomery got some great advice from the Secret Service before they guided the Presidents tour. A tour which included the Clean-Room and millions of dollars of equipment used in nano-research.

Read more:

Kids visit Nano College after Obama

Obama, Cuomo bond over vision of economic future

President Barack Obama, accompanied by New York Gov. Andrew Cuomo, center, holds a silicon wafer, as they tour the College of Nanoscale Science and Engineering at State University of New York at Albany's Nano-Tech complex, Tuesday, May 8, 2012, in Albany, N.Y., with Chris Borst, assistant V.P. for Engineering and Integration. Photo: Pablo Martinez Monsivais / AP

President Barack Obama, accompanied by New York Gov. Andrew Cuomo,...

President Barack Obama and New York Gov. Andrew Cuomo, right, tour the College of Nanoscale Science and Engineering at State University of New York at Albany's Nano-Tech complex, Tuesday, May 8, 2012, in Albany, N.Y. Photo: Pablo Martinez Monsivais / AP

President Barack Obama and New York Gov. Andrew Cuomo, right, tour...

President Barack Obama acknowledges New York Gov. Andrew Cuomo after being introduced at the University at Albany's College of Nanoscale Science and Engineering in Albany, N.Y., Tuesday, May 8, 2012. Photo: Mike Groll / AP

President Barack Obama acknowledges New York Gov. Andrew Cuomo...

President Barack Obama, and New York Gov. Andrew Cuomo, right, tour the College of Nanoscale Science and Engineering at State University of New York at Albany's Nano-Tech complex, Tuesday, May 8, 2012, in Albany, N.Y. Photo: Pablo Martinez Monsivais / AP

President Barack Obama, and New York Gov. Andrew Cuomo, right, tour...

New York Gov. Andrew Cuomo listens at left as President Barack Obama speaks during their tour at the College of Nanoscale Science and Engineering at State University of New York at Albany's Nano-Tech complex, Tuesday, May 8, 2012, in Albany, N.Y. Photo: Pablo Martinez Monsivais / AP

New York Gov. Andrew Cuomo listens at left as President Barack...

Read the rest here:

Obama, Cuomo bond over vision of economic future

Obama, Cuomo touring Nano college

ALBANY Instead of a new initiative or a dose of fresh funding, President Barack Obama used his third trip to the Capital Region to offer a "to do list" for Congress that included tax incentives and action to prevent student loan interest rates from doubling.

The Democratic President took the stage Tuesday in a half-finished clean room at the University at Albany's College of Nanoscale Science and Engineering to offer his election-year vision of the future.

"Now I want what's happening in Albany to happen all across the country places like Cleveland and Pittsburgh and Raleigh," Obama said. "I want to create more opportunities for hardworking Americans to start making things again, and selling them all over the world stamped with those proud words: Made in America. That's the goal."

The NanoCollege started as a bold idea several decades ago that today is helping to transform the region into a 21st century technology powerhouse.

While Obama didn't spend much of his 22-minute speech detailing the work in the facility, the President book-ended his remarks with praise about how the NanoCollege and New York state have helped create a high-tech manufacturing sector in upstate, with billions of dollars of both government and private sector investment. The site is undergoing a $4.8 billion expansion.

NanoCollege officials are hoping the visit could help convince the Obama administration to establish a Department of Defense presence at the school, a move that would open the door to billions of dollars in additional investment.

The President made no public mention of expanding the facility, but Alain Kaloyeros, the CEO of the NanoCollege, said Gov. Andrew Cuomo pitched Obama on the idea of DOD funding as he led the President on a tour of the school's facilities.

"The visit sets the stage for future partnerships with the federal government," Kaloyeros said. "The federal government is the only anchor tenant that is missing here. But it's not that we need them. They need us. There is so much that the Department of Defense could benefit from by being here."

But there were no new proposals on the President's "to do" list. Obama asked Congress to make it easier for homeowners to refinance their mortgages; create or extend tax credits for businesses that expand from overseas operations, hire new workers or use renewable energy; and create a job corps.

Republicans attacked the speech for its partisan tones, and criticized Obama for policies that would not apply more broadly.

Read more here:

Obama, Cuomo touring Nano college

Nano-Sensors for Explosive Detection — University Collaboration Addresses Challenges in Explosive Detection

ANN ARBOR, MI--(Marketwire -05/09/12)- This month, the Naval Engineering Education Center heads south to check in on the progress being made on a collaborative project involving Tennessee State University and Florida Atlantic University where NEEC investigators and students are looking at ways to detect explosives using nano-sensor technology while protecting troops, saving lives and building the future of our engineering workforce.

Explosive devices, like Improvised Explosive Devices (IEDs), are responsible for a significant amount of causalities to United States and NATO forces in Iraq and Afghanistan. In fact, according to a USA Today news story published last year, IEDs accounted for more than 40% of all deaths caused during the war in Afghanistan in 2010.

"Urban warfare has changed how we deal with wartime strategies," says Dr. S. Keith Hargrove, the NEEC Principal Investigator on the project and Dean of the College of Engineering at Tennessee State University. "Our NEEC research team is investigating methods to develop a new, improved, efficient way to detect explosives."

According to Professor Malkani Mohan, a Co-PI on this project from Tennessee State University, "Detecting explosives is a challenging task, which is complicated by low vapor pressures, frequent introduction of new explosive compositions, and novel concealment techniques. Trace detection of explosives usually requires collecting vapor or particulate samples and analyzing them with a sensitive sensor system. Many different techniques are currently used but they are bulky, expensive and difficult to deploy."

But this team's collaborative approach is unique in that they investigate micro- and nano-cantilever beam sensors for detection. Micro- and nano-cantilever beam sensors offer a distinct advantage in that they are small, very responsive and very sensitive. Furthermore, their sensitivity and selectivity can be tuned by modifying the surface treatment.

Both universities are both exposing underrepresented minorities to critical engineering challenges and careers which will benefit our country and the Navy. While Tennessee State University is an HBCU (Historically Black Colleges and Universities), Florida Atlantic University is a Minority-Serving Institution (MSI).

The full article that can be found at http://goneec.org/News/FeaturedResearch.aspx

The Naval Engineering Education Center (NEEC) is a consortium comprised of 15 institutions of higher education and two professional societies. Our goal is to develop the next generation of civilian engineers for the Navy through project-based education, collaboration, and curriculum development.

See more here:

Nano-Sensors for Explosive Detection -- University Collaboration Addresses Challenges in Explosive Detection

Genomics used to identify a molecular-based treatment for a viral skin cancer

ScienceDaily (May 9, 2012) Four years after they discovered the viral roots of a rare skin cancer, researchers at the University of Pittsburgh Cancer Institute (UPCI) and the School of Medicine have now identified a molecule activated by this virus that, in animal studies, could be targeted to selectively kill the tumor cells. The treatment will soon be tested in patients.

Merkel cell carcinoma (MCC), a skin cancer that is more common among seniors and those with weakened immune systems, could not be readily diagnosed at one time, and it still has a very poor prognosis, said Patrick S. Moore, M.D., M.P.H., and Yuan Chang, M.D., both of the Cancer Virology Program at UPCI and senior authors of a study that appears online May 9 in Science Translational Medicine.

"This research effort shows the speed at which genomics can identify molecular causes for cancer and then point the way toward a rational and targeted treatment," Dr. Moore noted. "Since the inception of the 1971 U.S. National Cancer Act, researchers have strived to discover the underlying problems that trigger tumor development."

In 2008, the team first described the new Merkel cell polyomavirus (MCV) in Merkel cell carcinoma. Within a year, they showed it was responsible for tumor development in most cases of the disease. At least four out of five healthy adults world-wide are infected with MCV, which usually doesn't cause any symptoms.

"The virus remains in the skin cells, and in most cases, no damage is done," Dr. Chang said. "But when mutations occur to this virus, it can cause cancer. Most of the 1,500 new MCC cases per year in the U.S. are caused by MCV infection."

In quick succession, the team devised tests to identify virus-induced MCC, and began unraveling the biochemical pathways that encourage tumor formation. In their latest project, they "knocked out" a key viral protein called T antigen and found that MCV directly elevates a cellular protein called survivin.

Survivin prevents cells from dying and supports cell division, the researchers said. They found that a drug called YM155, which turns off the survivin gene again, was an extremely potent killer of MCC cells in test tubes and was able to suppress the growth of human tumors that had been established in experimental mice. In comparison, 1,360 other drugs -- including most of the common chemotherapy drugs -- were screened and failed to both kill MCC cells and prevent tumor growth at levels commonly achieved in patients. One of these drugs was able to kill tumor cells in culture dishes, but made no impact on the MCC tumors in mice. It remains a promising candidate drug since it may have better activity in people and is readily available.

A multicenter clinical trial of YM155, a still-experimental anti-cancer drug that is made by Deerfield, Ill.-based Astellas, is expected to begin in the next six months to determine its effectiveness in MCC patients. The trial will be led locally by Pitt School of Medicine assistant professor Hussein Tawbi, M.D., Ph.D., and professor John Kirkwood, M.D., who also is co-leader of the UPCI Melanoma Program, through the Eastern Cooperative Oncology Group, a multicenter cooperative group supported by the National Cancer Institute (NCI), part of the National Institutes of Health.

Typically, neither the cause of a cancer nor the target for a cancer drug is initially known, so most treatments have developed over decades through trial-and-error. Most therapies affect both healthy tissues and cancer cells, resulting in side effects that limit the drug dose that can safely be given. This study, in contrast, was a "rational" drug study where the underlying cellular defect caused by the virus was first discovered through genetic studies and then a drug targeting this process was tested.Survivin is needed during fetal development, but not in healthy adult cells, and YM155 was not toxic to the mice.

"Scientists can now quickly come up with answers to complex problems, like cancer, using human genetics," Dr. Moore noted. "In less than five years, we have gone from knowing very little about MCC to knowing its exact cause and are devising new, precisely targeted and less-toxic therapies."

Original post:

Genomics used to identify a molecular-based treatment for a viral skin cancer

Pitt team uses genomics to identify a molecular-based treatment for a viral skin cancer

Public release date: 9-May-2012 [ | E-mail | Share ]

Contact: Anita Srikameswaran SrikamAV@upmc.edu 412-578-9193 University of Pittsburgh Schools of the Health Sciences

PITTSBURGH, May 9 Four years after they discovered the viral roots of a rare skin cancer, researchers at the University of Pittsburgh Cancer Institute (UPCI) and the School of Medicine have now identified a molecule activated by this virus that, in animal studies, could be targeted to selectively kill the tumor cells. The treatment will soon be tested in patients.

Merkel cell carcinoma (MCC), a skin cancer that is more common among seniors and those with weakened immune systems, could not be readily diagnosed at one time, and it still has a very poor prognosis, said Patrick S. Moore, M.D., M.P.H., and Yuan Chang, M.D., both of the Cancer Virology Program at UPCI and senior authors of a study that appears online today in Science Translational Medicine.

"This research effort shows the speed at which genomics can identify molecular causes for cancer and then point the way toward a rational and targeted treatment," Dr. Moore noted. "Since the inception of the 1971 U.S. National Cancer Act, researchers have strived to discover the underlying problems that trigger tumor development."

In 2008, the team first described the new Merkel cell polyomavirus (MCV) in Merkel cell carcinoma. Within a year, they showed it was responsible for tumor development in most cases of the disease. At least four out of five healthy adults world-wide are infected with MCV, which usually doesn't cause any symptoms.

"The virus remains in the skin cells, and in most cases, no damage is done," Dr. Chang said. "But when mutations occur to this virus, it can cause cancer. Most of the 1,500 new MCC cases per year in the U.S. are caused by MCV infection."

In quick succession, the team devised tests to identify virus-induced MCC, and began unraveling the biochemical pathways that encourage tumor formation. In their latest project, they "knocked out" a key viral protein called T antigen and found that MCV directly elevates a cellular protein called survivin.

Survivin prevents cells from dying and supports cell division, the researchers said. They found that a drug called YM155, which turns off the survivin gene again, was an extremely potent killer of MCC cells in test tubes and was able to suppress the growth of human tumors that had been established in experimental mice. In comparison, 1,360 other drugsincluding most of the common chemotherapy drugswere screened and failed to both kill MCC cells and prevent tumor growth at levels commonly achieved in patients. One of these drugs was able to kill tumor cells in culture dishes, but made no impact on the MCC tumors in mice. It remains a promising candidate drug since it may have better activity in people and is readily available.

A multicenter clinical trial of YM155, a still-experimental anti-cancer drug that is made by Deerfield, Ill.-based Astellas, is expected to begin in the next six months to determine its effectiveness in MCC patients. The trial will be led locally by Pitt School of Medicine assistant professor Hussein Tawbi, M.D., Ph.D., and professor John Kirkwood, M.D., who also is co-leader of the UPCI Melanoma Program, through the Eastern Cooperative Oncology Group, a multicenter cooperative group supported by the National Cancer Institute (NCI), part of the National Institutes of Health.

Read the original here:

Pitt team uses genomics to identify a molecular-based treatment for a viral skin cancer

In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers …

NEW YORK, May 9, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0849772/In-Vitro-Diagnostics-IVD-Market-Clinical-Chemistry-Immunoassays-Molecular-Diagnostics-Hematology-Analyzers--Microbiology-Culture--Global-Trends--Forecasts-to-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture) Global Trends & Forecasts to 2016

The global in-vitro diagnostics (IVD) market was valued at $44 billion in 2011 and is expected to have a modest growth during the study period. The U.S. represented the biggest market for IVD equipments accounting for about a half of the total market. The report studies various segments of the IVD market including Clinical Chemistry, Molecular diagnostics, Immunoassays, Hematology and Microbiology. Clinical chemistry dominates the global IVD market whereas molecular diagnostics is expected to register the highest growth during the study period. Increased patient awareness, patient self testing, rapidly aging population globally and automated testing due to technical advances are the major growth drivers of this market. Key players in the IVD market include Roche Diagnostics, Abbott Diagnostics, Beckman Coulter, BD Diagnostics, and Siemens Diagnostics.

1.1 KEY TAKE-AWAYS

1.2 REPORT DESCRIPTION

1.3 MARKETS COVERED

1.4 STAKEHOLDERS

1.5 RESEARCH METHODOLOGY

1.5.1 MARKET SIZE

View post:

In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers ...

NCKU Student Wins Prestigious Award for Anti-Cancer Research

TAINAN, Taiwan--(BUSINESS WIRE)--

Wan-Pei Su, a graduate student of Molecular Medicine at National Cheng Kung University (NCKU), southern Taiwan, has received a Graduate/Postdoctoral Travel Award from the American Society for Biochemistry and Molecular Biology (ASBMB) to attend the annual conference on Experimental Biology (EB) in San Diego in April 2012.

NCKU President Hwung-Hweng Hwung congratulated Su and her advisor, Dr. Nan-Shan Chang, director of NCKU Institute of Molecular Medicine, for winning international recognition. It is expected that the efforts put into the research will benefit the future clinical application, said Hwung.

Prof. Chang has been devoted to the discovery and development of the tumor suppressor WW domain-containing oxidoreductase (designated WWOX, FOR or WOX1). Zfra is one of the proteins which interact with WOX1. Su has carried on Changs research findings to anti-cancer mechanism.

Su is awarded for her research paper titled Self-polymerizing Zfra peptides elicit immune response for targeting cancer where the function of Zfra in anti-cancer therapy is investigated.

Zfra was first cloned by Dr. Changs group at the Guthrie Research Institute, Sayre, PA, USA in 2005, according to Su, and the role of Zfra in tumor necrosis factor signal pathway has aroused attention since then.

The most remarkable function of Zfra is its prevention of growth of skin cancer basal cell carcinoma, melanoma, prostate cancer, breast cancer and so on. It is foreseeable that Zfra can be used as a vaccine against all kinds of cancers, said Su.

Of all the 195 award recipients this year, mainly from North America and only 13 from Asia, 2 awardees come from Taiwan.

The ASBMB, founded in 1906 and now based in Maryland, is a prestigious, nonprofit scientific and educational organization with over 12,000 members. Many of them are highly regarded scientists, including Nobel laureates. ASBMB manages the publication of premier journals such as Journal of Biological Chemistry, Molecular & Cellular Proteomics, and Journal of Lipid Research.

Read the original post:

NCKU Student Wins Prestigious Award for Anti-Cancer Research

oJiiNz–x – MW2 Montage [RE-UPLOAD] – Video

08-05-2012 09:56 y0 wasup guy's, I closed my other YouTube channel by accident, lost 8k Subs & 39k Video Views. Please Like, Comment and share this Montage around to help me get this back to where it was. Sorry for it being 15 minutes long. Bare in mind alot of these clips are really old, Therefore don't hate 🙂 Editor: Songs in Order: Daughtry - No Surprise Red Jumpsuit Apparatus - False Pretense Red - Faceless Saosin - You Never Noticed Me Saosin - It's Far Better To Learn Red - Already Over I DO NOT OWN THE MUSIC ALL RIGHTS GO TO THE OWNERS! IGNORE THESE TAGS!!!! call of duty 5 beta gameplay multiplayer 4 COD5 COD 5 infinity ward xbox 360 microsoft sony playstation play station three 3 PS3 wii nintendo world war 2 WW2 WWII Gears of War GOW 2 1 halo 1 2 3 longshot pwnage owned own3d terrible nine year old n00b glitches terrible Nizmojoe clan exo outsider hitmanN nick nerd trash kid headshot blood gore idiot gears tourque bow grenade cod 1 2 3 4 knife Call of Duty 4 3 2 1 cod3 cod2 cod h2 h3 halo 3 CE Gears of War Infinity ward xbox360 xbox 360 ps3 PC wii doggietreats machinima digitalpheer melee marytdom steady aim mp5 desert eagle 50 cal m40a3 r700 m21 dragunov outstanding superb awesome the shit lol lmao rofle no scope head shot gears of war 2 rainbow six vegas ACOG m4 skorpion g3 g36c m14 ak47 mini uzi shotgun sniper xfycnx dizastor xfycnx iceman snowman gdawgum shadowpunish3r xfycnx iceman xbox gears of war 1 gow 1 mad world gary jules angel of evil ...

Excerpt from:

oJiiNz--x - MW2 Montage [RE-UPLOAD] - Video

Mojo – Peace Of Mind (Dubstep) [HD] – Video

08-05-2012 11:10 #fabiandofficial - #Best of Dubstep - #Mojo - Peace Of Mind Free Download ---------- Support the artist: ---------- Subscribe to my channel if you enjoyed! ---------- COPYRIGHT DISCLAIMER: I upload music for the entertainment of myself and others, I do NOT upload music inorder to make money nor do I upload music to take credit from the Artist(s) or another channel that was the first to upload it. If I have uploaded one of your tracks then I will happily add a link to your website; youtube channel or myspace etc. or if you are not happy that I have uploaded one of your tracks then simply send me a private message and I will remove it instantly.

Read the rest here:

Mojo - Peace Of Mind (Dubstep) [HD] - Video

What I Wore To Meadowhall: OOTD – Video

08-05-2012 13:03 OPEN ME UP Hi guys, I've been having some internet problems recently so I didn't get to upload the video I wanted to upload because it was longer so I thought I'd upload this one instead. Hope you don't mind, I'll try and have my skincare video up by the end of the week. WHAT AM I WEARING: Jumper: Primark Trousers: H&M Shoes: Vans Hat: Topshop Bag: Zara WHAT CAMERA DO I USE: Panasonic G2 Lumix WHERE TO FIND ME: Twitter: Blog: Email: Pinterest: Formspring:

Visit link:

What I Wore To Meadowhall: OOTD - Video

Poison Bait for Your Mind May 8, 2012 – Video

10-05-2012 01:32 Be happy and free..Watch out for what you allow into your mental regions. I've been learning about things like remote neural monitoring, mind uploading, neural highjacking, hypnosis by TV, psychotronic weapons, directed energy weapons, transhumanism, biochips and lots of new technologies that we really need to know about. Be centered in the right energies (Max Igan's advice) WATCH "TRANSFORMATION" by Max Igan...really interesting! Also, get silver and stay close to all you love and the Infinite Holy Spirit...^ ^ Thanks for watching!

Read more from the original source:

Poison Bait for Your Mind May 8, 2012 - Video

3G/4G Performance Map: Data Speeds for AT&T, Sprint, T-Mobile, and Verizon

In our April 16 article "3G and 4G Wireless Speed Showdown," we reported the results of our exclusive 13-city tests of the four national wireless services: AT&T, Sprint, T-Mobile, and Verizon. Our study is the largest and best-known independent test of wireless service in the United States.

Here, in Part Two of our story, we drill deeper into the massive amounts of data that we collected over six weeks in February and March of this year. Whereas the first article reported the 13-city average speeds of the carriers, in this story we detail the carriers' performance in each of the ten testing locations we visited in each city.

We've assembled a full-page map showing all 127 of our testing locations in Atlanta, Boston, Chicago, Dallas, Denver, Las Vegas, Los Angeles, New Orleans, New York, San Francisco, San Jose, Seattle, and Washington, D.C. When you zoom in on a particular city, you'll see ten blue map markers--one for each place we tested. Click the pin, and you'll see our full testing results for that location.

T-Mobile's HSPA+ 21 service dominated the 3G testing, earning the highest marks for upload speed and download speed in 11 of the 13 cities we studied. The exceptions were Chicago (where AT&T captured the best download and upload speeds for 3G) and Dallas (where AT&T took the lead for 3G downloads, and Verizon won for 3G uploads).

We saw three major patterns in our 4G test results. In five cities (Atlanta, Boston, Las Vegas, Los Angeles, and San Francisco), AT&T swept the 4G upload and download competitions; in four (Denver, New Orleans, San Jose, and Seattle), Verizon swept both; and in the remaining four (Chicago, Dallas, New York, and Washington, D.C.), AT&T won for downloads and Verizon prevailed for uploads. Notably, in two of the cities where Verizon ruled (Denver and Seattle), AT&T doesn't offer 4G LTE service.

Web Page and Video Load Times

In addition to the speed results, you can see the results of our "behavioral" tests, which are meant to closely approximate the wireless usage of real people. At each of our testing locations, our field researcher loaded a 100KB static Web page and viewed a 1-minute video while connected to each of the 3G and 4G services of the carriers. For each one, the researcher logged the time the Web page took to load, as well as the time necessary to stream the video.

In Video: Demystifying Spotty Cell Phone Coverage

You can see a lot of variance in the performance scores from location to location within our testing cities. The same service may deliver radically different results in two locations in the same part of town. Or two different wireless services might produce very different connection speeds and call quality at the same location.

Thats because a number of variables are constantly affecting the quality of the wireless service you get--factors such as nearby physical structures, your distance from a cell tower, whether you're connecting from indoors or outdoors, the time of day, and the total number of users connecting to a nearby cell tower at the same time.

See the rest here:

3G/4G Performance Map: Data Speeds for AT&T, Sprint, T-Mobile, and Verizon

How to Use the Internet Wisely, for Your Health and Your Country's

There's a lot of bad information out there online. This guide can help you avoid the crap and become a savvier citizen of our digital age.

addletters.com

Editor's note: The following essay has been adapted from Howard Rheingold's new book Net Smart: How to Thrive Online, which offers Rheingold's insights on how to find quality information on the web, and then how to piece that information together "intelligently, humanely, and above all mindfully." The book was published in April by MIT Press.

Use the following methods and tools to protect yourself from toxic bad info. Use them and then pass them along to others. Promote the notion that more info literacy is a practical answer to the growing info pollution. Be the change you want to see.

Although the Web undermines authority (by enabling anybody to publish), authority is still useful as one clue to credibility in a detective hunt that accounts for many other clues. Claims to authority, however, need to be questioned. I might add credibility to my assessment if a source is a verified professor at a known institution of higher learning, an authentic MD or PhD, but I would not subtract it from people without credentials whose expertise seems authentic. If you are going to grant credibility to people whose expertise is based on being a professor of something, make sure that assertion is accurate. Don't stop at simply verifying that the claim to be a professor is valid if you are looking for scientific credibility. The next step is to use the Faculty Scholarly Productivity Index that derives a score from the scholar's publications, citations by other scholars, grants, honors, and awards. If you want to get even more serious, download a free copy of Publish or Perish software, which analyzes scientific citations from Google Scholar according to multiple criteria. Or use the h-index to calculate how many times other scientists have cited a particular source. Again, don't trust just one source; triangulate.

Think of tools such as search engines, the productivity index, and hoax debunking sites as forensic instruments like Sherlock Holmes's magnifying glass or the crime scene investigator's fingerprint kit. For people who bet their health on online medical information, their economic well-being on online financial gossip, or their political liberty on the rumored news they get from Twitter, blogs, or YouTube, the stakes in this detective game are high. For example, you could triangulate by googling the author's name, entering the author's name in the Faculty Scholarly Productivity Index, and using the literacy resources at FactCheckED.org to triangulate a source. FactCheckED.org's sister site, FactCheck.org, researches claims by all political factions. How much stronger would democracies be if citizens checked the political section of the New York Times Company's"About Urban Legends" site or the U.S. Department of State's "Conspiracy Theories and Misinformation" site before passing along a link or an email about, respectively, a political figure or conspiracy theory?

How much work is it to check three links before believing or passing along online health information? Simply googling the name of the person who tried to sell do-it-yourself eye surgery kits, for example, immediately raises questions for those who are considering aiming lasers at their own retinas. Patients who want to learn more about their disease and treatment are not totally at the mercy of the oceans of rubbish. Tools for navigating research reports and treatment options exist. For scientific articles, ScienceDirect has guest access. The Health on the Net Foundation has been a steady source of finding reliable, credible health information online. It even has a browser plug-in that enables you to check health information on any Web site against its database. An astute medical student wrote a quality-check guide to medical information online. The Medical Library Association published "A User's Guide to Finding and Evaluating Health Information on the Web." Start with these gateways if you are new to seeking online medical information.

What person doesn't search online about their disease after they are diagnosed? According to the Pew Internet and American Life Project, "[Sixty-six percent] of Internet users look online for information about a specific disease or medical problem." In a Time magazine article, Zachary F. Meisel, an emergency physician and clinical scholar, describes the situation:

Meisel suggests that health care professionals encourage their patients to educate themselves about their diseases, and "guide their patients to Internet sites that exclusively present current, peer-reviewed and evidence-based health information." I'm cheered that in an international newsmagazine, a medical professional has publicly advised doctors to teach their patients the kind of crap detection that licensed practitioners learn to do early in their medical careers. Meisel, for instance, points to the Agency for Healthcare Research and Quality website that provides specific guidebooks for different diseases, directing patients with particular diseases to officially vetted research reports that compare different healthcare interventions.

The website Search Engine Watch, an industry source I consider knowledgeable, published a good article by Dean Stephens titled "Turning to Social Media and Search Engines for Smart Health Answers." In regard to getting answers, Stephens recommends MedHelp.org and JustAnswer.com for "detailed information specific to your question from health professionals," and favorably mentions Sharecare.com and Healthline.com. The Pew Internet and American Life Project claims that while medical professionals and Web searches are sources of some types of information for cancer patients, "when it comes to practical advice for coping with day-to-day health situations, people are as likely to turn to peers as they are to professionals."

More here:

How to Use the Internet Wisely, for Your Health and Your Country's